Brought to you by 
Aspen purchases international OTC medicines from GSK for £164mm
30 Jan 2023
Executive Summary
For £164mm ($263mm), GlaxoSmithKline PLC has sold to Aspen Pharmacare Holdings Ltd.--a South African pharmaco in which GSK holds a minority stake--a set of 19 deprioritized OTC products available in international markets.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- Marketing (Licensing)
- Product Purchase
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aspen purchases international OTC medicines from GSK for £164mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice